PMID- 37059367 OWN - NLM STAT- MEDLINE DCOM- 20230821 LR - 20230830 IS - 1097-6779 (Electronic) IS - 0016-5107 (Linking) VI - 98 IP - 3 DP - 2023 Sep TI - Comparison of the long-term outcomes of EUS-guided gallbladder drainage and endoscopic transpapillary gallbladder drainage for calculous cholecystitis in poor surgical candidates: a multicenter propensity score-matched analysis. PG - 362-370 LID - S0016-5107(23)00375-9 [pii] LID - 10.1016/j.gie.2023.04.002 [doi] AB - BACKGROUND AND AIMS: Although long-term stent placement using endoscopic transpapillary gallbladder drainage (ETGBD) and EUS-guided gallbladder drainage (EUS-GBD) reportedly reduces cholecystitis recurrence, comparative evidence of their safety and efficacy is scarce. This study aimed to examine and compare the long-term utility of EUS-GBD versus that of ETGBD in poor surgical candidates. METHODS: A total of 379 high-risk surgical patients with acute calculous cholecystitis met the eligibility criteria for enrollment in this study. The technical success and adverse events (AEs) were compared between the EUS-GBD and ETGBD groups, and propensity score matching was performed to adjust for differences between the groups. Both groups underwent plastic stent placement, and scheduled stent exchange and removal were not performed in either group. RESULTS: The technical success rate of EUS-GBD was significantly higher than that of ETGBD (96.7% vs 78.9%, P < .001), whereas the early AE rate did not differ significantly between the 2 methods (7.8% vs 8.9%, P = 1.000). The rate of recurrent cholecystitis did not differ significantly (3.8% vs 3.0%, P = 1.000), but the rate of symptomatic late AEs, in addition to cholecystitis, was significantly lower with EUS-GBD than with ETGBD (1.3% vs 13.4%, P = .006). Consequently, the overall late AE rate was significantly lower with EUS-GBD (5.0% vs 16.4%, P = .029). Multivariate analysis revealed that EUS-GBD was associated with a significantly longer time to late AE (hazard ratio, .26; 95% confidence interval, .10-.67; P = .005). CONCLUSIONS: Long-term stent placement via EUS-GBD is a promising potential option for limiting late AEs, including recurrence, in poor surgical candidates with calculous cholecystitis. CI - Copyright (c) 2023 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved. FAU - Inoue, Tadahisa AU - Inoue T AD - Department of Gastroenterology, Aichi Medical University, Yazakokarimata, Nagakute, Aichi, Japan. Electronic address: tinoue-tag@umin.ac.jp. FAU - Yoshida, Michihiro AU - Yoshida M AD - Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan. FAU - Suzuki, Yuta AU - Suzuki Y AD - Department of Gastroenterology, Gifu Prefectural Tajimi Hospital, Maehata-cho, Tajimi, Gifu, Japan. FAU - Kitano, Rena AU - Kitano R AD - Department of Gastroenterology, Aichi Medical University, Yazakokarimata, Nagakute, Aichi, Japan. FAU - Urakabe, Kenji AU - Urakabe K AD - Department of Gastroenterology, Gifu Prefectural Tajimi Hospital, Maehata-cho, Tajimi, Gifu, Japan. FAU - Haneda, Kenichi AU - Haneda K AD - Department of Gastroenterology, Gifu Prefectural Tajimi Hospital, Maehata-cho, Tajimi, Gifu, Japan. FAU - Okumura, Fumihiro AU - Okumura F AD - Department of Gastroenterology, Gifu Prefectural Tajimi Hospital, Maehata-cho, Tajimi, Gifu, Japan. FAU - Naitoh, Itaru AU - Naitoh I AD - Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan. LA - eng PT - Journal Article PT - Multicenter Study DEP - 20230412 PL - United States TA - Gastrointest Endosc JT - Gastrointestinal endoscopy JID - 0010505 SB - IM MH - Humans MH - Gallbladder/surgery/diagnostic imaging MH - Propensity Score MH - Endosonography/methods MH - *Cholecystitis/surgery/etiology MH - *Cholecystitis, Acute/surgery/etiology MH - Drainage/methods MH - Stents COIS- Disclosure The authors declare no conflicts of interest for this study. EDAT- 2023/04/15 06:00 MHDA- 2023/08/21 06:42 CRDT- 2023/04/14 19:29 PHST- 2022/12/14 00:00 [received] PHST- 2023/03/18 00:00 [revised] PHST- 2023/04/05 00:00 [accepted] PHST- 2023/08/21 06:42 [medline] PHST- 2023/04/15 06:00 [pubmed] PHST- 2023/04/14 19:29 [entrez] AID - S0016-5107(23)00375-9 [pii] AID - 10.1016/j.gie.2023.04.002 [doi] PST - ppublish SO - Gastrointest Endosc. 2023 Sep;98(3):362-370. doi: 10.1016/j.gie.2023.04.002. Epub 2023 Apr 12.